Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Barclays downgraded Illumina (ILMN) to Underweight from Equal Weight with a price target of $100, down from $130. The firm sees greater risk to ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

However, 10 companies defied a broader market optimism, mostly due to a series of stock rating downgrades from investment ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Puneet Souda, a research analyst for Leerink Partners, wrote in a research note Tuesday that Illumina’s inclusion on the list “appears more permanent posturing by China” rather than ...

HSBC raised shares of Illumina from a “hold” rating to a “buy” rating and set a $180.00 price target on the stock in a research note on Thursday, October 17th. Stephens raised their price ...

Illumina ILMN has outperformed the market over ... The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period ...